Chronic Myelogenous Leukemia

被引：62

作者：

O'Brien, Susan ^{[1
]}

Berman, Ellin

Borghaei, Hossein ^{[2
]}

DeAngelo, Daniel J. ^{[3
]}

Devetten, Marcel P.

Devine, Steven ^{[4
]}

Erba, Harry P. ^{[5
]}

Gotlib, Jason ^{[6
]}

Jagasia, Madan ^{[7
]}

Moore, Joseph O. ^{[8
]}

Mughal, Tariq ^{[9
]}

Radich, Jerald P. ^{[13
]}

Shah, Neil P.

Smith, B. Douglas ^{[12
]}

Snyder, David S. ^{[11
]}

Talpaz, Moshe ^{[10
]}

Wetzler, Meir ^{[6
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Mem Sloan Kettering Canc Ctr, New York, NY USA

[3] Fox Chase Canc Ctr, Philadelphia, PA USA

[4] Nebraska Med Ctr, UNMC Eppley Canc Ctr, Omaha, NE USA

[5] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Columbus, OH 43210 USA

[6] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

[7] Stanford Comprehens Canc Ctr, Stanford, CA USA

[8] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[9] Univ Tennessee, Inst Canc, St Jude Childrens Res Hosp, Knoxville, TN 37996 USA

[10] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[11] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Sidney, BC, Canada

[12] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[13] Fred Hutchinson Canc Res Ctr, Seattle, WA USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2009年 / 7卷 / 09期

关键词：

chronic myelogenous; leukemia; karyotyping; transplantation; imatinib; dasatinib; nilotinib; allogenic HSCT; hematologic response; cytogenetic response; CHRONIC MYELOID-LEUKEMIA; STEM-CELL TRANSPLANTATION; TYROSINE KINASE INHIBITOR; IMATINIB MESYLATE THERAPY; BONE-MARROW-TRANSPLANTATION; POLYMERASE-CHAIN-REACTION; IN-SITU HYBRIDIZATION; PATIENTS RECEIVING IMATINIB; BCR-ABL TRANSCRIPTS; HIGH-DOSE IMATINIB;

D O I：

10.6004/jnccn.2009.0065

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CML is a hematopoietic stem cell disease characterized by the presence of Ph chromosome resulting from the translocation between chromosomes 9 and 22 [t(9;22)]. © Journal of the National Comprehensive Cancer Network.

引用

页码：984 / 1023

页数：40

共 50 条

[1] CHRONIC MYELOGENOUS LEUKEMIA
不详
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1954, 155 (03): : 323 - 323
[2] Chronic myelogenous leukemia
Mauro, MJ
Druker, BJ
[J]. CURRENT OPINION IN ONCOLOGY, 2001, 13 (01) : 3 - 7
[3] CHRONIC MYELOGENOUS LEUKEMIA
MOLONEY, WC
[J]. CANCER, 1978, 42 (02) : 865 - 873
[4] CHRONIC MYELOGENOUS LEUKEMIA
GRIGNANI, F
[J]. CRC CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1985, 4 (01): : 31 - 66
[5] Chronic myelogenous leukemia
Willis, MS
Wilson, KS
[J]. LABORATORY MEDICINE, 2002, 33 (03) : 203 - 207
[6] Chronic myelogenous leukemia
O'Dwyer, ME
[J]. CURRENT OPINION IN ONCOLOGY, 2003, 15 (01) : 10 - 15
[7] Chronic myelogenous leukemia
Ernst, Thomas
Hochhaus, Andreas
[J]. ONKOLOGIE, 2023, 29 (04): : 305 - 314
[8] CHRONIC MYELOGENOUS LEUKEMIA
CARABASI, MH
[J]. CANCER INVESTIGATION, 1993, 11 (04) : 408 - 419
[9] Chronic Myelogenous Leukemia
O'Brien, Susan
Abboud, Camille N.
Akhtari, Mojtaba
Altman, Jessica
Berman, Ellin
DeAngelo, Daniel J.
Devine, Steven
Fathi, Amir T.
Gotlib, Jason
Jagasia, Madan
Moore, Joseph O.
Pinilla-Ibarz, Javier
Radich, Jerald P.
Reddy, Vishnu V. B.
Shah, Neil P.
Shami, Paul J.
Smith, B. Douglas
Snyder, David S.
Wetzler, Meir
Yunus, Furhan
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (01): : 64 - 110
[10] Chronic myelogenous leukemia
Gaal, K
Arber, DA
[J]. LABORATORY MEDICINE, 2000, 31 (10) : 557 - 562

← 1 2 3 4 5 →